Label: DR.PLINUS ZERO TROUBLE- gluconolactone, epigallocatechin gallatyl glucoside, madecassoside patch

  • NDC Code(s): 72630-030-01, 72630-030-02
  • Packager: S Skin Co., Ltd.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated October 18, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENTS

    Gluconolactone 2.14%
    Epigallocatechin Gallatyl Glucoside 0.05%
    Madecassoside 0.0013%(13ppm)

  • INACTIVE INGREDIENTS

    Sodium Hyaluronate, Water, Butylene Glycol, Niacinamide, Ectoin, 1.2-Hexanediol, Centella Asiatica Extract

  • PURPOSE

    Exfoliation
    Sebum control
    Calming

  • WARNINGS

    1. Discontinue to use or consult with dermatologist if irritation, swelling or itching appears after applying the product
    2. Avoid applying patches on the wounded, dermatitis, and inflamed skin parts
    3. Safety and storage precautions
    A) Keep out of children's reach
    B) Keep away from direct sunlight
    C) Use immediately after opening
    D) Do not reuse the patch you have already attached once
    E) For external use only

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of children's reach

  • Uses

    ■ Helps with exfoliation
    ■ Helps sebum control
    ■ Helps to soothe your skin

  • Directions

    ① Before using the patch, wash your face.
    ② Open the pouch and take the patches out from the clear case, and remove the protective films on patch
    (* one by one. At this point, be careful not to touch the middle part of the patch.)
    ③ Adjust the patches on your face where you concern and press lightly at a right angle.
    ④ Attach the patch above at least 60 minutes.

  • Other Information

    ■ Do not store this product in an inappropriate place such as high or low temperatures or under direct sun light

  • QUESTIONS

    ■ https://www.drplinus.com/ +82.1811.8665

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    Image of container

  • INGREDIENTS AND APPEARANCE
    DR.PLINUS ZERO TROUBLE 
    gluconolactone, epigallocatechin gallatyl glucoside, madecassoside patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72630-030
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GLUCONOLACTONE (UNII: WQ29KQ9POT) (GLUCONOLACTONE - UNII:WQ29KQ9POT) GLUCONOLACTONE0.029 mg  in 1.4 mg
    EPIGALLOCATECHIN GALLATYL GLUCOSIDE (UNII: AR8RR3M6N9) (EPIGALLOCATECHIN GALLATYL GLUCOSIDE - UNII:AR8RR3M6N9) EPIGALLOCATECHIN GALLATYL GLUCOSIDE0.0007 mg  in 1.4 mg
    Madecassoside (UNII: CQ2F5O6YIY) (Madecassoside - UNII:CQ2F5O6YIY) Madecassoside0.00001 mg  in 1.4 mg
    Inactive Ingredients
    Ingredient NameStrength
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    Water (UNII: 059QF0KO0R)  
    Butylene Glycol (UNII: 3XUS85K0RA)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72630-030-029 in 1 CONTAINER05/01/2021
    1NDC:72630-030-011.4 mg in 1 PATCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other05/01/2021
    Labeler - S Skin Co., Ltd. (694879753)
    Registrant - S Skin Co., Ltd. (694879753)
    Establishment
    NameAddressID/FEIBusiness Operations
    BIOCOSONE CO.,LTD695729438manufacture(72630-030)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!